title: Two distinct types of the inhibition of vasculogenesis by different species of charged particles.
abstract: BACKGROUND
  Charged particle radiation is known to be more biologically effective than photon radiation. One example of this is the inhibition of the formation of human blood vessels. This effect is an important factor influencing human health and is relevant to space travel as well as to cancer radiotherapy. We have previously shown that ion particles with a high energy deposition, or linear energy transfer (LET) are more than four times more effective at disrupting mature vessel tissue models than particles with a lower LET. For vasculogenesis however, the relative biological effectiveness between particles is the same. This unexpected result prompted us to investigate whether the inhibition of vasculogenesis was occurring by distinct mechanisms.
  
  
  METHODS
  Using 3-Dimensional human vessel models, we developed assays that determine at what stage angiogenesis is inhibited. Vessel morphology, the presence of motile tip structures, and changes in the matrix architecture were assessed. To confirm that the mechanisms are distinct, stimulation of Protein Kinase C (PKC) with phorbol ester (PMA) was employed to selectively restore vessel formation in cultures where early motile tip activity was inhibited.
  
  
  RESULTS
  Endothelial cells in 3-D culture exposed to low LET protons failed to make connections with other cells but eventually developed a central lumen. Conversely, cells exposed to high LET Fe charged particles extended cellular processes and made connections to other cells but did not develop a central lumen. The microtubule and actin cytoskeletons indicated that motility at the extending tips of endothelial cells is inhibited by low LET but not high LET particles. Actin-rich protrusive structures that contain bundled microtubules showed a 65% decrease when exposed to low LET particles but not high LET particles, with commensurate changes in the matrix architecture. Stimulation of PKC with PMA restored tip motility and capillary formation in low but not high LET particle treated cultures.
  
  
  CONCLUSIONS
  Low LET charged particles inhibit the early stages of vasculogenesis when tip cells have motile protrusive structures and are creating pioneer guidance tunnels through the matrix. High LET charged particles do not affect the early stages of vasculogenesis but they do affect the later stages when the endothelial cells migrate to form tubes.
authors.affiliation: Center for Radiological Research, Columbia University, VC 11-205A/243, 630 West 168th street, New York, NY 10032, USA. pwg2@columbia.edu.
authors.forename: Peter
authors.initials: P
authors.lastname: Grabham
authors.forename: Preety
authors.initials: P
authors.lastname: Sharma
authors.forename: Alan
authors.initials: A
authors.lastname: Bigelow
authors.forename: Charles
authors.initials: C
authors.lastname: Geard
references.citation: Exp Cell Res. 2009 Feb 1;315(3):396-410
references.pmid: 19041305
references.citation: J Vasc Res. 2011;48(5):369-85
references.pmid: 21464572
references.citation: J Cell Sci. 2003 Sep 15;116(Pt 18):3739-48
references.pmid: 12890754
references.citation: Blood. 2009 Jul 9;114(2):237-47
references.pmid: 19339693
references.citation: Radiat Res. 2012 Jul;178(1):33-45
references.pmid: 22702646
references.citation: Radiat Res. 2013 Mar;179(3):257-72
references.pmid: 23373900
references.citation: Arch Pharm Res. 2008 Jun;31(6):779-85
references.pmid: 18563361
references.citation: Science. 2013 May 31;340(6136):1080-4
references.pmid: 23723233
references.citation: Transl Oncol. 2008 Dec;1(4):195-201
references.pmid: 19043530
references.citation: Exp Cell Res. 1996 Apr 10;224(1):39-51
references.pmid: 8612690
references.citation: Radiat Res. 2010 Apr;173(4):486-93
references.pmid: 20334521
references.citation: Gravit Space Biol Bull. 2003 Jun;16(2):29-36
references.pmid: 12959129
references.citation: Int J Dev Biol. 2011;55(4-5):353-63
references.pmid: 21732275
references.citation: Adv Space Res. 2005;35(2):180-4
references.pmid: 15934192
references.citation: Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1518-26
references.pmid: 19906497
references.citation: Nat Rev Cancer. 2008 Jun;8(6):465-72
references.pmid: 18451812
references.citation: PLoS One. 2012;7(12):e53209
references.pmid: 23300891
references.citation: Radiat Prot Dosimetry. 2005;115(1-4):44-50
references.pmid: 16381680
references.citation: Int J Radiat Biol. 2012 Jun;88(6):493-500
references.pmid: 22449005
references.citation: J Clin Pharmacol. 2004 Aug;44(8):837-53
references.pmid: 15286087
references.citation: Catheter Cardiovasc Interv. 2008 Oct 1;72(4):563-8
references.pmid: 18819153
references.citation: Radiology. 1946 Nov;47(5):487-91
references.pmid: 20274616
references.citation: Radiat Res. 2011 Jan;175(1):21-8
references.pmid: 21175343
references.citation: Lancet Oncol. 2006 May;7(5):431-5
references.pmid: 16648048
references.citation: Radiat Res. 2003 Oct;160(4):381-407
references.pmid: 12968934
references.citation: Cancer Res. 2003 Jul 15;63(14):4253-7
references.pmid: 12874034